P3BEP
01 Dec 2020
Trial Summary
The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.
Acronym:
ANZUP 1302
ACTRN/NCT /ethics:
NCT02582697
Scientific title:
Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Sponsor / Cooperative group:
University of Sydney
Trial & Patient Characteristics
| Cancer Type | Other |
|---|---|
| Trial Type | Treatment |
| Phase | Phase III |
| Age Range | 11-45 years |
| Sex | Male |
| Tumour Stream | Germ cell |
| Cancer Stage | Locally Recurrent or Locally Advanced |
| Anticipated Start Date | 2014-02-01 |
| Anticipated End Date | 2023-07-01 |
Participating Hospitals
| Hospital | Ashford Cancer Centre Research |
|---|---|
| Clinical Trial Coordinator | Sue Yeend |
| syeend@adelaidecancercentre.com.au | |
| Phone | 08 8292 2240 |
| Principal Investigator | Professor Hsing Tan |
| Recruitment Status | Recruitment on Hold |
| Hospital | Flinders Medical Centre |
|---|---|
| Clinical Trial Coordinator | Alex Scott-Hoy |
| alex.scott-hoy@sa.gov.au | |
| Phone | 08 8204 4830 |
| Principal Investigator | - |
| Recruitment Status | Recruiting |
| Hospital | Royal Adelaide Hospital |
|---|---|
| Clinical Trial Coordinator | Anne Milton |
| anne.milton@sa.gov.au | |
| Phone | 08 7074 2342 |
| Principal Investigator | Dr Hsiang Tan |
| Recruitment Status | Recruiting |